Jian-Guo Wu1, Jin-Jie Wang1, Xin Jiang1, Jian-Ping Lan2, Xu-Jun He3, Hui-Ju Wang3, Ying-Yu Ma3, Ying-Jie Xia3, Guo-Qing Ru2, Jie Ma2, Zhong-Sheng Zhao4, Ren Zhou5. 1. Department of Pathology and Pathophysiology, Zhejiang University School of Medicine, Hangzhou, 310058, People's Republic of China. 2. Department of Pathology, Zhejiang Provincal People's Hospital, Hangzhou, 310014, People's Republic of China. 3. Key Laboratory of Gastroenterology of Zhejiang Province, Hangzhou, 310014, People's Republic of China. 4. Department of Pathology, Zhejiang Provincal People's Hospital, Hangzhou, 310014, People's Republic of China. zhaozhongsheng1950@163.com. 5. Department of Pathology and Pathophysiology, Zhejiang University School of Medicine, Hangzhou, 310058, People's Republic of China. zhouren@zju.edu.cn.
Abstract
BACKGROUND: MiR-125b functions as an oncogene in many cancers; however, its clinical significance and molecular mechanism in gastric cancers have never been sufficiently investigated. Here, we elucidated the functions and molecular regulated pathways of MiR-125b in gastric cancer. METHODS: We investigated MiR-125b expression in fresh tissues from 50 gastric cancer patients and 6 gastric cancer cell lines using RT-PCR, and explored its prognostic value by hybridizing MiR-125b in situ for 300 clinical gastric tumor tissues with pathological diagnosis and clinical parameters. The effects of MiR-125b on gastric cancer cells and downstream target genes and proteins were analyzed by MTT, transwell assay, RT-PCR, and western blot on the basis of silencing MiR-125b in vitro. Luciferase reporter plasmid was constructed to demonstrate MiR-125b's direct target. RESULTS: MiR-125b was upregulated in gastric cancer tissues and cell lines, and significantly promoted cellular proliferation, migration, and invasion by downregulating the expression of PPP1CA and upregulating Rb phosphorylation. MiR-125b expression was significantly correlated with tumor size and depth of invasion, lymph nodes, distant metastasis, and TNM stage. The high-MiR-125b-expression group had a significantly poorer prognosis than the low-expression group (P < 0.05) in stages I, II, and III, and the 5-year survival rate in of the high-expression group was significantly lower than that of the low-expression group. CONCLUSIONS: MiR-125b functions as an oncogene by targeting downregulated PPP1CA and upregulated Rb phosphorylation in gastric cancer. MiR-125b not only promotes cellular proliferation, migration, and invasion in vitro, but also acts as an independent prognostic factor in gastric cancer.
BACKGROUND:MiR-125b functions as an oncogene in many cancers; however, its clinical significance and molecular mechanism in gastric cancers have never been sufficiently investigated. Here, we elucidated the functions and molecular regulated pathways of MiR-125b in gastric cancer. METHODS: We investigated MiR-125b expression in fresh tissues from 50 gastric cancerpatients and 6 gastric cancer cell lines using RT-PCR, and explored its prognostic value by hybridizing MiR-125b in situ for 300 clinical gastric tumor tissues with pathological diagnosis and clinical parameters. The effects of MiR-125b on gastric cancer cells and downstream target genes and proteins were analyzed by MTT, transwell assay, RT-PCR, and western blot on the basis of silencing MiR-125b in vitro. Luciferase reporter plasmid was constructed to demonstrate MiR-125b's direct target. RESULTS:MiR-125b was upregulated in gastric cancer tissues and cell lines, and significantly promoted cellular proliferation, migration, and invasion by downregulating the expression of PPP1CA and upregulating Rb phosphorylation. MiR-125b expression was significantly correlated with tumor size and depth of invasion, lymph nodes, distant metastasis, and TNM stage. The high-MiR-125b-expression group had a significantly poorer prognosis than the low-expression group (P < 0.05) in stages I, II, and III, and the 5-year survival rate in of the high-expression group was significantly lower than that of the low-expression group. CONCLUSIONS:MiR-125b functions as an oncogene by targeting downregulated PPP1CA and upregulated Rb phosphorylation in gastric cancer. MiR-125b not only promotes cellular proliferation, migration, and invasion in vitro, but also acts as an independent prognostic factor in gastric cancer.
Authors: Peter T Nelson; Don A Baldwin; Wigard P Kloosterman; Sakari Kauppinen; Ronald H A Plasterk; Zissimos Mourelatos Journal: RNA Date: 2005-12-22 Impact factor: 4.942
Authors: Stefano Volinia; George A Calin; Chang-Gong Liu; Stefan Ambs; Amelia Cimmino; Fabio Petrocca; Rosa Visone; Marilena Iorio; Claudia Roldo; Manuela Ferracin; Robyn L Prueitt; Nozumu Yanaihara; Giovanni Lanza; Aldo Scarpa; Andrea Vecchione; Massimo Negrini; Curtis C Harris; Carlo M Croce Journal: Proc Natl Acad Sci U S A Date: 2006-02-03 Impact factor: 11.205
Authors: Hyuna Sung; Howard H Yang; Han Zhang; Qi Yang; Nan Hu; Ze-Zhong Tang; Hua Su; Lemin Wang; Chaoyu Wang; Ti Ding; Jin-Hu Fan; You-Lin Qiao; William Wheeler; Carol Giffen; Laurie Burdett; Zhaoming Wang; Maxwell P Lee; Stephen J Chanock; Sanford M Dawsey; Neal D Freedman; Christian C Abnet; Alisa M Goldstein; Kai Yu; Philip R Taylor; Paula L Hyland Journal: Int J Epidemiol Date: 2015-04-27 Impact factor: 7.196